期刊文献+

脑钠肽与非ST段抬高的急性冠状动脉综合征严重程度及预后的关系 被引量:1

Correlation of natriuretic peptide level with severity and prognosis in patients with non-ST elevation acute coronary syndrome
原文传递
导出
摘要 目的探讨非ST段抬高的急性冠状动脉综合征(NSTEACS)患者血浆脑钠肽(BNP)浓度与疾病严重程度及预后的关系。方法NSTEACS患者132例,其中不稳定型心绞痛(UA)94例,非ST段抬高的心肌梗死(NSTEMI)38例,检测其血浆BNP、高敏C反应蛋白(CRP)和肌钙蛋白I(cTnI)浓度。对UA患者进行Braunwald分级,对NSTEMI进行Killip分级;1周内行冠状动脉造影,并随访6个月,根据随访期间不良事件的有无将患者分为不良事件和无不良事件组,比较2组BNP、CRP、cTnI水平。结果随着Braunwald和Killip分级增高,2组血浆BNP浓度均增高,且每两级间差异有统计学意义(均P〈0.05);在不良事件组,血浆BNP、CRP、cTnI浓度均显著高于无不良事件组。结论NSTEACS患者血浆BNP浓度与疾病严重程度及不良预后相关。 Objective To explore the correlation of serum-B-type natriuretic peptide level(BNP) with the severity and the prognosis in patients with non-ST elevation acute coronary syndrome ( NSTEACS ). Methods 132 patients with NSTEACS were chosen, including 94 with UA, 38 with NSTEMI. The patients with UA was separated by Braunwald classification and those with NSTEMI were separated by Killip classification when their venous blood were collected to measure and analyze the level of BNP, CRP and cTnI. Coronary angiographies were performed in a week. According to 6 months follow-up of adverse cardiac events, patients were divided into Group A ( with adverse cardiac events) and Group B (without adverse cardiac events), and the BNP, CRP, cTnI level was compared, Resuits With the upgrading of Braunwald and Killip classification, the concentrations of BNP in both groups increased and there was significant difference between each two classes( P 〈0.05 ). Plasma concentrations of BNP, CRP, and cTnI in patients of Group B increased much more than those in patients of Group A. Conclusion Plasma concentration of BNP in patients with NSTEACS might be correlated with the degree of the disease and the adverse prognosis.
出处 《中国综合临床》 北大核心 2007年第5期411-413,共3页 Clinical Medicine of China
关键词 急性冠状动脉综合彳正 脑钠肽 高敏C反应蛋白 Acute' coronary syndrome B-type natriuretic peptide High-sensitive C-reactive protein
  • 相关文献

参考文献8

  • 1Galvani M,Ferrini D, Oani F. Natriurctic pcptidcs for risk stratification of patients with acute coronary syndromes[ J ]. Eur J Heart Fail,2004,6(3) :327-333.
  • 2Kikuta K, Yasue H, Yoshimura M, et al. Increased plasma levels of B-type Natriuretic Peptide in patients with unstable angina[J]. Am Heart J,1996,132(1 Pt 1) :101-107.
  • 3Sadanandan S,Cannon CP,Chekuri K,et al. Association of elevated B-type natriurctic peptide levels with angiographic findings among patients with unstable angina and non-ST segment devation myocardial infarction[J]. J Am Coll Cardiol,2004,44(3) :564-568.
  • 4Mrrow DA, Cannon CP, Rifai N, et al. Ability of minor elevation of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infraction:result from a randomized trial[J]. JAMA,2001,286(19) :2405-2412.
  • 5Antman EM, Tanasijevic MJ, Thompson B, cl al. Cardiac-specific eroponin I levels to predict the risk of mortality in patients with acute coronary syndromes[J]. N Engl J Mcd, 1996,335 ( 18 ) : 1342-1349.
  • 6Sabatine MS. Multimarker approach to risk stratification in non-ST-elevation acute coronary syndromes: simultaneous assessment of troponin Ⅰ, C-reactive protein, and B-type natriuretic peptide[ J ]. Circulation ,2002,105 ( 15 ) : 1760-1736.
  • 7James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain Natriuretie peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a global utilization of strategies to open occluded arteries ( GUSTO ) -Ⅳ substudy [ J ]. Circulation,2003,108(3) :275-281.
  • 8Horio T, Shimada K, Kohno M, et al. Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty [ J ]. Am Heart J, 1993,126(2) :293-299.

同被引文献13

  • 1de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natri~etic peptide in patients with acute coronary syndromes [J]. N Eng J Med,2001,345 (14) :1014-1021.
  • 2Weisel JW. Fibrinogen and fibrin[ J ]. Adv Protein Chem,2005,70: 247-299.
  • 3Iwanaga Y, Nishi I, Furuichi S, et ai. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure : Comparison between systolic and diastolic heart failure[ J]. J Am Coll Cardiol,2006,47(4) :742-748.
  • 4Suzuki T,Yamazaki T,Yazaki Y. The role of the natriuretie peptide in the cardiovascular system[ J]. Cardiovasc Res,2001,51 (3) :489- 494.
  • 5Asada J ,Tsuji H, Iwasaka T, et al. Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine induced myocardial ischemia[ J]. Am J Cardiol,2004,93 (6) :702-704.
  • 6Hopkins WE, Chen Z, Fukagawa NK, et al. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease : enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion [ J ]. Circulation, 2004, 109 (23) :2872-2877.
  • 7Morita E, Yasue H, Yoshimura M, et al. Increased plasma levels of brain natriuretie peptide in patients with acute myocardial infarction [J]. Circulation, 1993,88( 1 ) :82-91.
  • 8Yildirir A, Acikel S, Ertan C, et al. Effects of lesion complexity on baseline and postproeedural B-type natriuretie peptide levels in pa- tients undergoing pereutaneous coronary interventions[ J ]. Tex Heart Inst J,2007,34(3) :282-289.
  • 9Grahowski M, Filipiak K J, Karpinski G. Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty [ J ]. Am Heart J,2004,148(4) :655-662.
  • 10Michela V, Francesco Z, Maria BD, et al. Analysis of gene environment interaction in coronary heart disease:fibrinogen polymorphisms as an example[J]. Ital Heart J,2002,3(1) :18-23.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部